Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner.
Saved in:
| Title: | Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. |
|---|---|
| Authors: | Whitehead CA; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia., Fang H; Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Su H; Centre for Stem Cell Systems, The University of Melbourne, Parkville, VIC, Australia.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia., Morokoff AP; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Level 5, Clinical Sciences Building, Parkville, VIC, 3050, Australia., Kaye AH; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Department of Neurosurgery, Hadassah Hebrew University Medical Centre, Jerusalem, Israel., Hanssen E; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, VIC, 3010, Australia.; Advanced Microscopy Facility, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, 3010, Australia., Nowell CJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, 3052, Australia., Drummond KJ; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Level 5, Clinical Sciences Building, Parkville, VIC, 3050, Australia., Greening DW; Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Baker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, VIC, Australia.; Central Clinical School, Monash University, Melbourne, VIC, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC, Australia., Vella LJ; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Centre for Stem Cell Systems, The University of Melbourne, Parkville, VIC, Australia., Mantamadiotis T; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia.; Centre for Stem Cell Systems, The University of Melbourne, Parkville, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Melbourne, VIC, Australia., Stylli SS; Department of Surgery, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, Australia. sstylli@unimelb.edu.au.; Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Level 5, Clinical Sciences Building, Parkville, VIC, 3050, Australia. sstylli@unimelb.edu.au. |
| Source: | Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2023 Aug; Vol. 46 (4), pp. 909-931. Date of Electronic Publication: 2023 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2211-3436 |
|---|---|
| DOI: | 10.1007/s13402-023-00786-w |
